Government Failure in Regulating Health Insurance

We all agree that healthcare is essential. But health insurance? That’s a different beast-it’s complicated, expensive, and often confusing. When markets struggle to provide fair or affordable coverage (what economists call “market failure”), we instinctively turn to the government to step in. We ask it to regulate prices, mandate coverage, and protect consumers. The intention is always good: to make healthcare more accessible and fair. But what happens when the “cure” supplied by the government ends up being as bad as, or even worse than, the original disease? This is the core of an economic concept known as government failure.

It’s a tricky idea to discuss. It’s not about accusing politicians of being “bad” or public servants of being “lazy.” Instead, it’s a sober look at how political and bureaucratic systems operate. It suggests that, just like markets, governments can also be inefficient and produce undesirable outcomes. When it comes to something as complex as health insurance, these failures can have massive consequences, from skyrocketing premiums to services that look good on paper but are impossible to access in reality.

Let’s explore why even the most well-intentioned government intervention in the health insurance market can go wrong.

What is government failure anyway? 🔗

Before we pinpoint the problem, let’s set the stage. Economists often talk about market failure. In health insurance, this happens in several ways. A classic example is adverse selection: if insurers can’t tell who is high-risk (sick) versus low-risk (healthy), the healthy people might find the premiums too high and drop out, leaving only the sick in the pool. This causes premiums to spiral upwards until the market collapses. Another is information asymmetry, where your doctor or hospital knows much more about the treatment you need than you do, giving them the power to over-prescribe or over-charge.

Given these real problems, the government is asked to intervene. It might create a public insurance program, regulate what all plans must cover, or set prices. Government failure occurs when this intervention, designed to fix the market failure, doesn’t actually improve things. In fact, it might make them worse by creating new inefficiencies, distortions, or unintended consequences.

Think of it like this: your car’s engine (the market) is running poorly. You take it to a mechanic (the government). Government failure is when the mechanic, in an attempt to fix the carburetor, accidentally disconnects the brake line. The original problem might be partially fixed, but a new, potentially more dangerous, one has been created.

The politician and the lobbyist: a public choice story 🔗

One of the most powerful explanations for government failure comes from Public Choice Theory. This school of thought, championed by economists like James Buchanan, is essentially “economics for politics.” It starts with a simple, revolutionary assumption: politicians, voters, and bureaucrats are rational actors, just like consumers or business owners. They tend to act in ways that maximize their own self-interest, not necessarily the abstract “public good.”

A politician’s “interest” might be getting re-elected. A bureaucrat’s might be increasing their department’s budget or influence. A voter’s might be supporting a policy that benefits them directly, even if it costs society more overall. When you apply this lens to regulation, you get a very different picture of how rules are made.

The logic of concentrated benefits and diffused costs 🔗

Here’s the core of the problem: a small, well-organized group has a massive stake in a specific policy, while the general public has a tiny, almost unnoticeable stake. Imagine a lobby representing a chain of specialty hospitals. They want a new regulation that mandates all public and private insurance plans must cover a specific expensive procedure they offer. For them, this regulation is worth crores of rupees. They will hire lawyers, fund research, meet with regulators, and donate to political campaigns to make it happen. Their benefit is highly concentrated.

Now, who pays for this? The public. This new mandate might add just ₹200 per year to every person’s insurance premium. The cost is widely diffused. Will you take a day off work, research the policy, and organize a protest over ₹200? Of course not. It’s not worth your time. The regulator or politician, therefore, faces a simple choice:

1. Grant the regulation, gaining the powerful, focused support of the hospital lobby.
2. Deny the regulation, facing the lobby’s anger, while getting zero praise from the public (who never even noticed the fight).

Public choice theory suggests they will almost always choose option one. The political process is skewed to favor small, organized special interests at the expense of the large, unorganized public. This isn’t corruption in the illegal sense; it’s simply how the incentives of the system are aligned.

How this plays out in health insurance 🔗

This “special interest” effect pops up everywhere in health insurance regulation:

• Mandated Benefits: As in the example above, lobbies for specific treatments, provider groups (like chiropractors or acupuncturists), or pharmaceutical companies constantly push for their services to be included in all insurance packages. This drives up the cost of a “basic” plan for everyone.
• Rate Setting: When the government sets the reimbursement rates for public schemes (like Ayushman Bharat PM-JAY in India), hospitals and doctor associations lobby intensely for higher rates. Public insurance companies or state governments push for lower rates. The final rate is often the result of political bargaining, not a cold, hard analysis of actual costs, potentially leading to challenges in viability or provider participation.
• Entry Barriers: Existing, large insurance companies might lobby for complex and expensive licensing requirements. They frame this as “protecting consumers,” but it also serves to block new, innovative startups from entering the market and competing with them.

The result is a regulatory framework that looks like a patchwork quilt of special favors, ultimately making insurance more expensive and complex for the average person.

The problem with the process: bureaucracy and inefficiency 🔗

The second major source of government failure is administrative. Even if a policy is perfectly designed (a rare feat!), it must be implemented by a government agency or bureaucracy. Unlike a private business, public agencies face very different incentives.

The biggest difference is the lack of market discipline. If a private insurance company is inefficient, has terrible customer service, or uses outdated technology, its customers will leave and go to a competitor. It will lose money and eventually shut down. This is the “profit and loss” mechanism. A government agency faces no such threat. It can be inefficient, slow, and provide poor service, but it won’t go bankrupt. Its budget is allocated by the legislature, not earned from satisfied customers.

When costs are underestimated and benefits are overestimated 🔗

This lack of a “bottom line” creates a dangerous incentive. As many public sector analyses show, bureaucrats and their political supporters often have an incentive to expand their programs. A larger program often means a larger budget, more staff, and greater prestige. Effective governance requires strong accountability, but this is hard to achieve.

When a new public health program or regulation is proposed, its proponents (both in the agency and in politics) have a strong incentive to:

1. Overstate the benefits: “This program will save millions of lives and cover every last citizen!”
2. Understate the costs: “This can be run with a small team and will cost only X.”

Once the program is launched and becomes popular with its beneficiaries, it becomes politically impossible to shut down, even when the true costs are revealed to be five or ten times the original estimate. We see this in public health schemes around the world, where initial budgets balloon over time as administrative complexities, fraud, and higher-than-expected usage are revealed. Reports from bodies like NITI Aayog often highlight these exact gaps in coverage and financing, pointing to the immense challenge of designing a scheme that is both comprehensive and financially sustainable.

[Image: A complex flowchart showing the multiple bureaucratic steps for a single health insurance claim approval]

Technical vs. allocative inefficiency 🔗

This bureaucratic drift leads to two types of inefficiency:

• Technical Inefficiency: This is about not getting the most “bang for the buck.” It’s about doing things in a costly or wasteful way. For example, a government claims-processing office might still use an outdated paper-based system, requiring dozens of clerks, when a private firm would have implemented an AI-driven digital system. This is the “how” of the failure.
• Allocative Inefficiency: This is about doing the *wrong things* entirely. The government might spend its health budget “inefficiently” by building a single, high-tech specialty hospital in a major city (which looks impressive and pleases urban elites) while neglecting to fund basic primary care clinics in rural areas where the health impact per rupee spent would be much higher.

In health insurance regulation, an agency like India’s IRDAI might be technically inefficient if its approval process for new, innovative insurance products is so slow and cumbersome that it stifles competition. It might be allocatively inefficient if it focuses all its resources on regulating minor wording in policy documents while failing to tackle systemic issues like hospital fraud or provider cartels.

So, is all government intervention bad? 🔗

After all this, it’s easy to think the message is “government is bad, market is good.” But that is absolutely not the takeaway. The concept of government failure isn’t an argument for anarchy; it’s a vital warning. It cautions us that intervention is not a magic wand. The existence of a market failure does not automatically justify any and all government action.

The true task for policymakers is to be clear-eyed and weigh two imperfect options. We must compare the very real costs of imperfect markets (like adverse selection) against the very real costs of imperfect government (like regulatory capture and bureaucracy). Often, the choice is not between a “bad” market and a “good” government, but between two flawed systems.

The performance of a nation’s healthcare system ultimately depends less on whether it’s “private” or “public” and more on *how it is managed*. A well-designed public system with strong accountability, clear incentives, and transparency can outperform a poorly regulated private market. And a well-regulated private market can outperform a bloated, inefficient public bureaucracy. Recognizing the potential for government failure is the first step toward designing smarter, more efficient, and more accountable interventions that actually help people.

What do you think?

Have you ever experienced a bureaucratic rule in healthcare or insurance that seemed to create more problems than it solved? Given the risks of both market failure and government failure, what do you think is the single most important thing regulators should focus on?

References

1. https://www.econlib.org/library/Enc/PublicChoice.html
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996611/
3. https://www.worldbank.org/en/topic/governance
4. https://www.niti.gov.in/sites/default/files/2021-10/Health-Insurance-for-Indias-Missing-Middle.pdf